DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sitia G, Iannacone M, Müller S, Bianchi ME, Guidotti LG.
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice.
J Leukoc Biol 2007;
81 (1) 100-107
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.